Immune Deficiency Foundation Company Profile

03:43 EDT 23rd September 2017 | BioPortfolio

News Articles [2022 Associated News Articles listed on BioPortfolio]

Primary Immune Deficiency PID Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's Primary Immune Deficiency PID Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Primary Immune Deficiency PID in seven major markets US, France, Germany, It...

Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation

Primary Immune Deficiency PID Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 31072017] Prices from USD $5750

DelveInsight's Primary Immune Deficiency PID Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Primary Immune Defici...

President Obama Signs into Law Medicare IVIG Access Act

WASHINGTON, Jan. 10, 2013 /PRNewswire/ -- The Immune Deficiency Foundation (IDF), the national patient organization dedicated to improving the lives of persons with primary immunodeficiency disea...

Bubble boy hope: Strimvelis gene therapy revises genetic make-up, offers rare immune deficiency cure

Michael S. Hershfield, M.D. Awarded the Boyle Scientific Achievement Award at Immune Deficiency Foundation 2013 National Conference

TOWSON, Md., June 28, 2013 /PRNewswire/ -- The Immune Deficiency Foundation (IDF) announced today that Michael S. Hershfield, M.D. has been awarded the Boyle Scientific Achievement Award for...

Primary Immune Deficiency PID Pipeline Insight, 2017 [Report Updated: 31072017] Prices from USD $1250

DelveInsight's, Primary Immune Deficiency PIDPipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Primary Immune Deficiency PID. T...

Immune Deficiency Foundation Statement on "Everything, Everything"

TOWSON, Md., May 10, 2017 /PRNewswire-USNewswire/ -- Later this month, MGM Studios and Warner Bros. Pictures will release Everything, Everything, a movie based on a book of the same name by Nicola Yoo...

Drugs and Medications [784 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [3181 Associated PubMed Articles listed on BioPortfolio]

Immune-mediated cytopenia in pediatric primary immune deficiency patients following HSCT.

Nutritional modulation of age-related changes in the immune system and risk of infection.

The immune system undergoes some adverse alterations during aging, many of which have been implicated in the increased morbidity and mortality associated with infection in the elderly. In addition to ...

Granzyme A-deficiency breaks immune tolerance and promotes Autoimmune Diabetes Through a Type I Interferon-Dependent Pathway.

Granzyme A is a protease implicated in the degradation of intracellular DNA. Nucleotide complexes are known triggers of systemic autoimmunity, but a role in organ-specific autoimmune disease has not b...

Immune deficiency and rosacea.

They wonder whether the patients that we reported definitely had demodicidosis associated to rosacea, and above all provide, they their own interesting findings in 60 patients with rosacea, findings t...

Unusual retinopathy in a child with severe combined immune deficiency.

We describe a case of an infant diagnosed with severe combined immune deficiency (Adenosine Deaminase (ADA), SCID) with severe retinopathy and associated low vision in both eyes at first examination. ...

Clinical Trials [3572 Associated Clinical Trials listed on BioPortfolio]

Alpha-1 Foundation Research Registry

The Alpha-1 Foundation Research Registry is a confidential database made up of individuals diagnosed with severe alpha-1 antitrypsin deficiency (Alpha-1) or the carrier state.

Participation in a Research Registry for Immune Disorders

Background: - People with primary immune deficiency diseases (PIDD) have weak immune systems. This makes it hard for their bodies to fight infection. The Immune Deficiency Foundation has ...

Open Label Phase 3 Study of NABI-IGIV 10% [(HUMAN)] In Subjects With Primary Immune Deficiency Disorders (PIDD)

The purpose of this study is to determine if NABI-IGIV (10%) is safe and effective in preventing serious bacterial infections in the treatment of patients with primary immune deficiency di...

Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease

Some Primary Immune Deficiencies can be associated with an inflammatory bowel disease, mimicking Crohn disease : the Chronic Granulomatous Disease (CGD), the XIAP deficiency, and the TTC7A...

Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States

This study investigates gene abnormalities in Primary Immune Deficiency(PID) with a goal of improving the diagnosis and treatment of patients. The specific disorders include: 1....

Companies [1773 Associated Companies listed on BioPortfolio]

Immune Deficiency Foundation

Alpha-1 Foundation and Foundation for Sarcoidosis Research

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...

Alpha-1 Foundation

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...

Diagnostica & Analys Service AB

Haemophilia caused by Factor VIII - or Factor IX deficiency and von Willebrand disease have long been possible to diagnose, but with some difficulties for the latter. In the mid 1970's Antithrombin II...

The Alpha-1 Project

Mission statement: The Alpha-1 Project will work with patients, academia, pharmaceutical and biotech companies, and public health organizations in the relentless pursuit of cures ...

More Information about "Immune Deficiency Foundation" on BioPortfolio

We have published hundreds of Immune Deficiency Foundation news stories on BioPortfolio along with dozens of Immune Deficiency Foundation Clinical Trials and PubMed Articles about Immune Deficiency Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immune Deficiency Foundation Companies in our database. You can also find out about relevant Immune Deficiency Foundation Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record